Gliwice/ A team of doctors has developed an innovative receptor diagnostic for disseminated breast cancer
Go to the source page
A team of doctors from the Gliwice-based National Cancer Institute has performed non-invasive imaging of the HER2 receptor using PET radioimmunoassay in a patient with disseminated breast cancer, the institution announced Monday.
Moderators' opinion:
Unverified information
Comments
Be the first to comment!